Drugs / Ex-vivo expanded effector cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00439465 | Jan 2007 → Oct 2012 | plasma cell myeloma | Dartmouth-Hitchcock Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ex-vivo expanded effector cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00439465 ↗ |
| Modality | Cell therapy | “highly effective "killer" cells (cytotoxic T cells)” NCT00439465 ↗ |